Buprenorphine (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Buprenorphine drug offered from Teva Pharmaceuticals USA, Inc.. This Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
NON-PROPRIETARY NAME: | Buprenorphine |
SUBSTANCE NAME: | BUPRENORPHINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA] |
ROUTE: | TRANSDERMAL |
DOSAGE FORM: | PATCH, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2017-05-30 |
END MARKETING DATE: | 0000-00-00 |
Buprenorphine HUMAN PRESCRIPTION DRUG Details:
Item Description | Buprenorphine from Teva Pharmaceuticals USA, Inc. |
LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
DEA SCHEDULE: | CIII
|
ACTIVE STRENGTH: | 5(ug/h) |
START MARKETING DATE: | 2017-05-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0093-3600_6f01f14e-5b47-4544-9656-d471cebe03ee |
PRODUCT NDC: | 0093-3600 |
APPLICATION NUMBER: | NDA021306 |
Other BUPRENORPHINE Pharmaceutical Manufacturers / Labelers: